Skip to content
OpenCapital
Get started

Haemonetics HAE Quick ratio

Quick ratio at other companies

Abbott logo
AbbottABT
1×-0.3×
TFX
TeleflexTFX
2×+0.7×
Boston Scientific logo
Boston ScientificBSX
1.2×+0.3×
Medtronic logo
MedtronicMDT
1.6×+0.2×
LivaNova logo
LivaNovaLIVN
1.1×-0.3×
ICU Medical logo
ICU MedicalICUI
1.2×-0.3×

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio3×+1.3×

Where this comes from

Calculated from Haemonetics’s reported figures.

quick assets/total current liabilities=1.9×

Based on the most recent quarter.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's quick ratio?
Haemonetics (HAE) reported quick ratio of 1.9× in Q1 2026.
How has Haemonetics's quick ratio changed year-over-year?
Haemonetics's quick ratio increased by 89.7% year-over-year, from 1× to 1.9×.
What is the long-term trend for Haemonetics's quick ratio?
Over 5 years (2021 to 2026), Haemonetics's quick ratio has grown at a 5.0% compound annual growth rate (CAGR), from 1.5× to 1.9×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.